期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
The 2019 novel coronavirus disease(COVID-19) pandemic: A zoonotic prospective 被引量:5
1
作者 Chiranjib Chakraborty Ashish Ranjan Sharma +2 位作者 manojit bhattacharya Garima Sharma Sang-Soo Lee 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2020年第6期242-246,共5页
Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),a novel coronavirus(CoV),has recently emerged as a significant pathogen for humans and the cause for the recent outbreak of the 2019 novel coronavirus diseas... Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),a novel coronavirus(CoV),has recently emerged as a significant pathogen for humans and the cause for the recent outbreak of the 2019 novel coronavirus disease(COVID-19)throughout the globe.For developing any preventive measure,an understanding of the zoonotic pattern for this virus is a necessity.We should have a clear knowledge of its reservoir host,its distribution pattern and spreading routes.Information about zoonotic reservoirs and its transmission among them can help to understand the COVID-19 outbreaks.In this article,we discuss about the bats as the zoonotic reservoir of several CoV strains,co-existence of bats and CoV/viruses,the sequence similarity of SARS-CoV-2 with bat SARS-like CoV,the probable source of the origin of SARS-CoV-2 strain and COVID-19 outbreak,intermediate host of CoVs and SARS-CoV-2,human to human transmission and the possibility to maintain the zoonotic barriers.Our knowledge about the zoonotic reservoir of SARS-CoV-2 and its transmission ability may help develop the preventive measures and control for the future outbreak of CoV. 展开更多
关键词 SARS-CoV-2 COVID-19 CORONAVIRUS Zoonotic reservoir
下载PDF
The bacteriophage mu lysis system–A new mechanism of host lysis?
2
作者 SAIKAT SAMANTA ASHISH RANJAN SHARMA +6 位作者 ABINIT SAHA MANOJ KUMAR SINGH ARPITA DAS manojit bhattacharya RUDRA PRASAD SAHA SANG-SOO LEE CHIRANJIB CHAKRABORTY 《BIOCELL》 SCIE 2021年第5期1175-1186,共12页
Bacteriophages are viruses that infect bacteria and can choose any one of the two alternative pathways for infection,i.e.,lysis or lysogeny.Phage lysis is one of the conventional biological processes required to sprea... Bacteriophages are viruses that infect bacteria and can choose any one of the two alternative pathways for infection,i.e.,lysis or lysogeny.Phage lysis is one of the conventional biological processes required to spread infection from one bacterium to another.Our analysis suggests that in the paradigm bacteriophage Mu,six proteins might be involved in host cell lysis.Mu has a broad host range,and Mu-like phages were found in both Gram-negative and Gram-positive bacteria.An analysis of the genomes of Mu and Mu-like phages could be useful in elucidating the lysis mechanism in this group of phages.A detailed review of the various mechanisms of phage lysis and different proteins associated with the process will help researchers understand the phage biology and their life cycle in different bacteria.The recent increase in the number of multidrug-resistant(MDR)strains of bacteria and the usual long-term nature of new drug development has encouraged scientists to look for alternative strategies like phage therapy and the discovery of new lysis mechanisms.Understanding the lysis mechanism in the Mu-like phages could be exploited to develop alternative therapeutics to kill drug-resistant pathogenic bacteria.In this review article,we have analyzed the phage Mu-mediated host lysis system,which is unknown till now,and our analysis indicates a possibility of the existence of a new lysis mechanism operating in Mu. 展开更多
关键词 Bacteriophage Mu Host cell lysis ENDOLYSIN HOLIN Spanin
下载PDF
PPARγLBD and its ligand specificity reveal a selection of potential partial agonist:Molecular dynamics based T2D drug discovery initiative
3
作者 BIDYUT MALLICK ASHISH RANJAN SHARMA +2 位作者 manojit bhattacharya SANG-SOO LEE CHIRANJIB CHAKRABORTY 《BIOCELL》 SCIE 2021年第4期953-961,共9页
PPARγis a peroxisome proliferator-activated receptor(PPAR)family protein and is a target for type 2 diabetes(T2D).In this paper,we have performed a molecular docking analysis between ligand molecules(CID9816265,CID11... PPARγis a peroxisome proliferator-activated receptor(PPAR)family protein and is a target for type 2 diabetes(T2D).In this paper,we have performed a molecular docking analysis between ligand molecules(CID9816265,CID11608015,CID20251380,CID20251343,CID20556263,CID624491,CID42609928,and CID86287562)and PPARγto determine the ligand specificity.It also helps to understand the ligand-binding domain(LBD)activity of PPARγduring the binding of the ligand.Further,a molecular dynamics simulation study was performed to determine the ligand biding stability in the PPARγLBD.Its ligand specificity informed us about the potentiality of selecting a partial agonist.The study also shows the binding conformation of Ceramicine B having hydrogen bonding affinity with a tricyclic polar head and stabilized theβ-sheet region.On the other hand,the tricyclic polar head of nimbolide also formed hydrogen bonding(Ser342),but it shows a lesser degree of stabilization in theβ-sheet region.It shows the binding conformation of partial agonist(PPARγ)in the Pocket-II of PPARγLBD,which has a significant role in stabilizing theβ-sheet region.It might help to regulate ERK/Cdk5 mediated phosphorylation of Ser245.The study helps us understand the valid pose of a set of ligands confirmation and target protein conformation using docking and molecular dynamics study.This in silico study will also help to initiate a drug discovery process of T2D. 展开更多
关键词 PPARΓ Partial agonist Molecular simulation T2D Drug discovery
下载PDF
Altered gut microbiota patterns in COVID-19:Markers for inflammation and disease severity
4
作者 Chiranjib Chakraborty Ashish Ranjan Sharma +2 位作者 manojit bhattacharya Kuldeep Dhama Sang-Soo Lee 《World Journal of Gastroenterology》 SCIE CAS 2022年第25期2802-2822,共21页
The severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection leads to a severe respiratory illness and alters the gut microbiota,which dynamically interacts with the human immune system.Microbiota alterati... The severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection leads to a severe respiratory illness and alters the gut microbiota,which dynamically interacts with the human immune system.Microbiota alterations include decreased levels of beneficial bacteria and augmentation of opportunistic pathogens.Here,we describe critical factors affecting the microbiota in coronavirus disease 2019(COVID-19)patients.These include,such as gut microbiota imbalance and gastrointestinal symptoms,the pattern of altered gut microbiota composition in COVID-19 patients,and crosstalk between the microbiome and the gut-lung axis/gut-brain-lung axis.Moreover,we have illustrated the hypoxia state in COVID-19 associated gut microbiota alteration.The role of ACE2 in the digestive system,and control of its expression using the gut microbiota is discussed,highlighting the interactions between the lungs,the gut,and the brain during COVID-19 infection.Similarly,we address the gut microbiota in elderly or co-morbid patients as well as gut microbiota dysbiosis of in severe COVID-19.Several clinical trials to understand the role of probiotics in COVID-19 patients are listed in this review.Augmented inflammation is one of the major driving forces for COVID-19 symptoms and gut microbiome disruption and is associated with disease severity.However,understanding the role of the gut microbiota in immune modulation during SARS-CoV-2 infection may help improve therapeutic strategies for COVID-19 treatment. 展开更多
关键词 COVID-19 INFLAMMATION Gut microbiota THERAPEUTIC
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部